2013 - 2014 EVENTS
"HIV in the 21st Century: Going from Treatment, to Prevention, to Cure"
Myron S. Cohen, MD
Associate Vice Chancellor for Global Health
Yeargan-Bate Eminent Professor of Medicine, Microbiology, Immunology & Epidemiology
Director, Institute for Global Health and Infectious Diseases
Chief, Division of Infectious Diseases
University of North Carolina at Chapel Hill
Thursday, January 24, 2014
P&S Alumni Auditorium
650 West 168th Street, First Floor
Myron S. Cohen is the Yeargan-Bate Eminent Professor of Medicine, Microbiology and Immunology, and Public Health at the University of North Carolina at Chapel Hill.
Dr. Cohen received his BS degree, Magna Cum Laude, from the University of Illinois, Champaign-Urbana. He received an MD degree from Rush Medical College in Chicago. He completed training in internal medicine at the University of Michigan and training in infectious diseases at Yale University. He is a Fellow of the American College of Physicians and the Infectious Disease Society of America and a member of the Institute of Medicine, the American Society of Clinical Investigation, and the American Association of Physicians. Dr. Cohen serves as Director of the UNC Division of Infectious Diseases and the UNC Institute for Global Health and Infectious Diseases and as Associate Vice Chancellor for Global Health. Dr. Cohen serves as the co-principal investigator of the NIH HIV Prevention Trials Network (HPTN).
Dr. Cohen received the Distinguished Alumnus Award from Rush Medical College in 2000. He received the Distinguished Career Award for lifetime achievement in STD/HIV research from the American Sexually Transmitted Diseases Association in 2005. In 2008 Dr. Cohen received the O. Max Gardner Award, the highest honor in the University of North Carolina System. He received a Special Citation from the Infectious Disease Society in 2012 for his work in global HIV prevention. Dr. Cohen has been recognized for more than a decade as one of America's "Top Doctors" and "Best Doctors."
Dr. Cohen helped to develop laboratory methods to measure HIV in genital secretions as well as methods to determine the best antiviral agents to reduce replication of HIV in these compartments. For this work Dr. Cohen has received more than 25 years of continuous funding from the National Institutes of Health, including an NIH MERIT Award. Dr. Cohen is the architect and principal investigator of the multinational HPTN 052 trial, which demonstrated that antiretroviral treatment of people with HIV infection prevents the sexual transmission of the virus. This work was recognized by Science Magazine as the "Breakthrough of the Year" in 2011. The HPTN 052 study has led to worldwide changes in the treatment and prevention of HIV infection and helped to galvanize hope for an "AIDS-free generation."
Dr. Cohen is the author of more than 500 publications. He has written extensively about the prevention of HIV infection. Much of Dr. Cohen's research has been conducted over the past three decades in resource-constrained countries, especially Malawi, and in the People's Republic of China.
2012-2013 Daniel H. Lowenstein, M.D., University of California, San Francisco
2011-2012 Lawrence M. Tierney Jr., M.D., University of California, San Francisco
2010 - 2011 David Valle, M.D, Johns Hopkins University, School of Medicine
C. Ronald Kahn, M.D.
2008-2009 L.D. Britt, M.D., Eastern Virginia Medical School